Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Sell
34
PJP Quote, Financials, Valuation and Earnings
Last price:
$78.96
Seasonality move
:
3.63%
Day range:
$79.38 - $80.10
52-week range:
$72.25 - $89.87
Dividend yield:
1.14%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
16.2K
Avg. volume:
10.8K
1-year change:
0.91%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
$79.84 | -- | -- | -- | $0.27 | 1.14% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$62.97 | -- | -- | -- | $0.03 | 0.07% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$79.30 | -- | -- | -- | $0.01 | 0.17% | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
$82.32 | -- | -- | -- | $0.03 | 0.04% | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
$132.16 | -- | -- | -- | $0.56 | 1.77% | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
$40.17 | -- | -- | -- | $0.15 | 1.64% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.581 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 1.183 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.543 | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | 1.636 | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 0.887 | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | 0.578 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns PJP or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About PJP or PBE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is PJP or PBE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.530, which suggesting that the stock is 46.992% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.840, suggesting its less volatile than the S&P 500 by 15.98%.
-
Which is a Better Dividend Stock PJP or PBE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.14%. Invesco Biotechnology & Genome ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or PBE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns PJP or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About PJP or XBI?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is PJP or XBI More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.530, which suggesting that the stock is 46.992% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.396%.
-
Which is a Better Dividend Stock PJP or XBI?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.14%. SPDR S&P Biotech ETF offers a yield of 0.17% to investors and pays a quarterly dividend of $0.01 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XBI?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns PJP or XHE?
SPDR S&P Health Care Equipment ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About PJP or XHE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XHESPDR S&P Health Care Equipment ETF0 0 0 -
Is PJP or XHE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.530, which suggesting that the stock is 46.992% less volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.069, suggesting its more volatile than the S&P 500 by 6.861%.
-
Which is a Better Dividend Stock PJP or XHE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.14%. SPDR S&P Health Care Equipment ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.03 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XHE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- --
-
Which has Higher Returns PJP or XLV?
Health Care Select Sector SPDR Fund has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- -
What do Analysts Say About PJP or XLV?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe Invesco Pharmaceuticals ETF is more attractive than Health Care Select Sector SPDR Fund.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XLVHealth Care Select Sector SPDR Fund0 0 0 -
Is PJP or XLV More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.530, which suggesting that the stock is 46.992% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.691, suggesting its less volatile than the S&P 500 by 30.908%.
-
Which is a Better Dividend Stock PJP or XLV?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.14%. Health Care Select Sector SPDR Fund offers a yield of 1.77% to investors and pays a quarterly dividend of $0.56 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XLV?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- --
-
Which has Higher Returns PJP or XPH?
SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About PJP or XPH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XPHSPDR S&P Pharmaceuticals ETF0 0 0 -
Is PJP or XPH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.530, which suggesting that the stock is 46.992% less volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.646, suggesting its less volatile than the S&P 500 by 35.443%.
-
Which is a Better Dividend Stock PJP or XPH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.14%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.64% to investors and pays a quarterly dividend of $0.15 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XPH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
